RxDoctor Payments Data

Megan Kish

Physician Assistant · Leesburg, VANPI 1467017137

Payments from drug & device makers

$4,776in general payments, 2019–2025

Across 218 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$735
  • Novo Nordisk$599
  • GSK$372
  • Astellas Pharma US Inc$286
  • Lilly USA, LLC$233
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$4,70198%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,776 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide47$70,005
OzempicSemaglutide24$30,654
FarxigaDapagliflozin Propanediol18$17,241
Atorvastatin Calcium89$711
Valsartan15$692
Levothyroxine Sodium25$390
Losartan Potassium25$351
Lisinopril58$310
Duloxetine Hcl14$302
Tamsulosin Hcl17$225
Celecoxib16$178
Amlodipine Besylate44$170
Metformin Hcl35$164
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$160
Rosuvastatin Calcium23$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$233$70,00547 claims
Novo NordiskOzempic$599$30,65424 claims
AstraZenecaFarxiga$735$17,24118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →